About ONdrugDelivery

Established in 2004, ONdrugDelivery is trusted throughout the pharma and biotech sector, and known as the magazine which focuses right down on specific topics within drug delivery with each issue.

It's always free to subscribe to ONdrugDelivery Magazine in electronic format. A print subscriptions is just £189/year (9/10 issues).

ONdrugDelivery Magazine has an excellent reputation for trustworthy, cutting-edge content, regular loyal support from leading companies (from the very largest to the very smallest), and a truly global, combined print and PDF readership topping 30,000. We have also built a strong social media presence with well in excess of 4,500 Facebook followers and growing Twitter and LinkedIn following.

With a commercial perspective, the series has been specifically designed, based on the publisher's deep knowledge and clear understanding of the science and business of drug delivery, to meet the needs of its readers worldwide.

Each edition focuses on one specific topic within the field of drug delivery (see editorial calendar for details).
The unique ONdrugDelivery publications offer a valuable lead in two important ways:

  1. With ONdrugDelivery, the degree of topic specialisation is unmatched. Readers know, just from viewing the title of a given edition, whether it is or is not on a topic that they are interested in. When a topic of interest is identified, they can be sure that from cover to cover, the publication will be of real value.
  2. ONdrugDelivery offers a place for companies developing delivery systems and related technologies and services, to present themselves – alongside others competing in the same space – through arguably the most the readily accessible and useful media of all – detailed, well written, strictly edited and immaculately presented feature articles.

Those in the pharmaceutical and biotechnology sectors, whose role it is to seek novel delivery systems and pair these with their own companies' research and product development programmes, agree. These are ONdrugDelivery's readers. They absolutely require this information from the drug delivery sector. ONdrugDelivery fulfils this requirement absolutely.